Abraham N. Oler
2021
In 2021, Abraham N. Oler earned a total compensation of $1.1M as Senior Vice President, Corporate Development and General Counsel at Onconova Therapeutics.
Compensation breakdown
| Bonus | $139,875 |
|---|---|
| Option Awards | $180,089 |
| Salary | $375,000 |
| Stock Awards | $383,588 |
| Other | $14,739 |
| Total | $1,093,291 |
Oler received $383.6K in stock awards, accounting for 35% of the total pay in 2021.
Oler also received $139.9K in bonus, $180.1K in option awards, $375K in salary and $14.7K in other compensation.
Rankings
In 2021, Abraham N. Oler's compensation ranked 8,484th out of 12,415 executives tracked by ExecPay. In other words, Oler earned more than 31.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,484 out of 12,415 | 32nd |
Division Manufacturing | 3,761 out of 5,508 | 32nd |
Major group Chemicals And Allied Products | 1,666 out of 2,378 | 30th |
Industry group Drugs | 1,483 out of 2,099 | 29th |
Industry Pharmaceutical Preparations | 1,104 out of 1,549 | 29th |
Source: SEC filing on May 25, 2022.
Oler's colleagues
We found two more compensation records of executives who worked with Abraham N. Oler at Onconova Therapeutics in 2021.